文献速递医学教育与科研方法临床试验与 GCP

工作人员对涉及撤除治疗的临床试验收尾工作的体验:定性研究

Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study.
PubMed 文献 · Trials · 2017-02-07

该定性研究访谈了来自七个试验点的22名工作人员,探讨其在涉及撤除胰岛素泵治疗的试验收尾阶段的体验。工作人员描述了诸多伦理与情感挑战,包括患者对撤除治疗的焦虑、初始知情同意是否仍有效、资金压力与临床标准冲突,以及决策在不同试验点间的差异。作者认为,更充分的规划、协调与伦理监督可减轻或预防部分挑战。

要点

  • 涉及撤除治疗的试验收尾可给工作人员带来未预见的伦理与情感挑战。
  • 患者对撤除治疗日益焦虑,工作人员需考量初始知情同意是否仍然有效。
  • 工作人员在希波克拉底个体主义与功利主义伦理间两难,决策因试验点而异。

核心结论

  • 试验开始时可能困扰工作人员的伦理问题(如患者对试验参与有不切实际的期望、工作人员经历研究与临床角色的冲突)可能在试验结束时再次出现。
  • 作者认为,为保障工作人员和患者的福祉,涉及撤除治疗的试验收尾应投入更多的规划、协调与伦理监督。

研究设计与样本

  • 定性研究,对来自七个试验点的22名工作人员进行访谈,数据采用主题分析法分析。
  • 试验注册:国际标准随机对照试验编号(ISRCTN)注册库,ISRCTN61215213,注册日期2011年5月11日。

主要发现

  • 工作人员描述了收尾阶段大量在试验开始时未预见的伦理与情感挑战。
  • 关键挑战是患者虽在了解泵治疗可能被撤除的前提下同意参与,但常以未能预见的方式从该方案中获益,因而随着试验进展对撤除治疗日益焦虑。
  • 这一情况迫使工作人员考虑患者最初给出的同意是否仍然有效,并在收尾时面临两难:许多希望继续使用泵的患者不符合试验后资助所需的临床标准。
  • 工作人员在决定是否撤除治疗时需考虑资金压力和患者痛苦,并发现自己处于希波克拉底个体主义与功利主义伦理之间。
  • 这些冲突压力与伦理考量导致工作人员的决策在不同试验点间存在差异,部分人将此描述为进一步的伦理不安来源。

临床怎么用

  • 作者认为,为保障工作人员和患者的福祉,涉及撤除治疗的试验收尾应投入更多的规划、协调与伦理监督。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ending of a clinical trial may be challenging, particularly if staff are required to withdraw the investigated treatment(s); however, this aspect of trial work is surprisingly under-researched. To address this gap, we explored the experiences of staff involved in closing out a trial that entailed withdrawal of treatment (insulin pumps) from some patients. METHODS: Interviews were conducted with n = 22 staff, recruited from seven trial sites. Data were analysed thematically. RESULTS: Staff described a myriad of ethical and emotional challenges at closeout, many of which had been unforeseen when the trial began. A key challenge for staff was that, while patients gave their agreement to participate on the understanding that pump treatment could be withdrawn, they often found themselves benefitting from this regimen in ways they could not have foreseen. Hence, as the trial progressed, patients became increasingly anxious about withdrawal of treatment. This situation forced staff to consider whether the consent patients had given at the outset remained valid; it also presented them with a dilemma at closeout because many of those who had wanted to remain on a pump did not meet the clinical criteria required for post-trial funding. When deciding whether to withdraw treatment, staff not only had to take funding pressures and patient distress into account, but they also found themselves caught between an ethic of Hippocratic individualism and one of utilitarianism. These conflicting pressures and ethical considerations resulted in staff decision-making varying across the sites, an issue that some described as a further source of ethical unease. Staff concluded that, had there been more advanced planning and discussion, and greater accountability to an ethics committee, some of the challenges they had confronted at closeout could have been lessened or even prevented. CONCLUSIONS: The same kinds of ethical issues that may vex staff at the beginning of a trial (e.g. patients having unrealistic expectations of trial participation; staff experiencing conflicts between research and clinical roles) may re-present themselves at the end. To safeguard the wellbeing of staff and patients, greater planning, coordination and ethical oversight should go into the closeout of trials involving withdrawal of treatment(s). TRIAL REGISTRATION: International Standard Randomised Controlled Trials Number (ISRCTN) Registry, ISRCTN61215213 . Registered on 11 May 2011.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lawton J, White D, Rankin D, et al. Staff experiences of closing out a clinical trial involving withdrawal of treatment: qualitative study. Trials. 2017. PMID: 28173843. doi:10.1186/s13063-017-1813-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。